NASDAQ:NUVA
Delisted
NuVasive Stock News
$39.75
+0 (+0%)
At Close: Nov 30, 2023
New Strong Buy Stocks for April 26th
09:08am, Wednesday, 26'th Apr 2023
EGY, MSGS, NUVA, NWG and VCISY have been added to the Zacks Rank #1 (Strong Buy) List on April 26, 2022.
NUVA vs. ABT: Which Stock Is the Better Value Option?
12:57pm, Tuesday, 25'th Apr 2023
Investors looking for stocks in the Medical - Products sector might want to consider either NuVasive (NUVA) or Abbott (ABT). But which of these two stocks is more attractive to value investors?
PR Newswire SAN DIEGO, April 17, 2023
Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
02:21pm, Friday, 14'th Apr 2023
SAN DIEGO , April 14, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integ
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, In
Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?
12:59pm, Friday, 24'th Mar 2023
NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock?
NuVasive's (NUVA) Precice System Cleared for Pediatric Patients
09:13am, Tuesday, 21'st Mar 2023
NuVasive (NUVA) receives FDA 510(k) clearance for using the Precice limb lengthening system for treating pediatric patients.
NuVasive (NUVA), GMED Merger Aids, Macro Woes Mar Growth
11:30am, Friday, 17'th Mar 2023
According to NuVasive (NUVA), the combined company is set to have an advanced commercial scale and portfolio of clinically proven solutions.
Bear of the Day: NuVasive (NUVA)
07:32am, Thursday, 02'nd Mar 2023
Softer results for spinal surgery innovator plus questionable merger have dropped estimates and shares
NuVasive to Participate in Upcoming Investor Conferences
04:10pm, Monday, 27'th Feb 2023
SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
NuVasive (NUVA) Q4 Earnings Miss Estimates, Margins Down
12:48pm, Thursday, 23'rd Feb 2023
Inflationary costs, supply chain disruptions, volatility in foreign exchange rates and the persistent COVID-led impact hurt NuVasive's (NUVA) Q4 revenues.
NuVasive, Inc. (NUVA) Q4 2022 Earnings Call Transcript
09:08pm, Wednesday, 22'nd Feb 2023
NuVasive, Inc. (NASDAQ:NUVA ) Q4 2022 Earnings Conference Call February 22, 2023 4:30 PM ET Company Participants Juliet Cunningham - VP, IR Christopher Barry - CEO & Director Matthew Harbaugh - EVP &
NuVasive (NUVA) Q4 Earnings and Revenues Miss Estimates
07:34pm, Wednesday, 22'nd Feb 2023
NuVasive (NUVA) delivered earnings and revenue surprises of -12.24% and 1.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Globus And NuVasive Take Spinal Fusion To A New Level
05:11am, Sunday, 12'th Feb 2023
Globus and NuVasive agreed to merge in a deal that will see Globus acquire its spinal surgery rival for 0.75 shares of GMED per NUVA share (or $3.1B). Globus shares sold off sharply, as the Street cle
Globus Medical to Buy NuVasive in $3.1 Billion Deal
07:33am, Thursday, 09'th Feb 2023
The implied price for NuVasive under terms of the deal is $57.72 a share.
